Morfin Orifarm (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride Trihydrate, the active ingredient in Morfin Orifarm, is an opioid analgesic presented as a parenteral preparation for intramuscular, intravenous, subcutaneous use. It is used to manage severe acute pain, postoperative pain, and cancer‑related pain in adult patients. GNH USA supplies Morfin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine Hydrochloride acts on the opioid pain pathway to provide potent analgesia in several clinical settings. - Severe acute pain: provides rapid relief of intense pain episodes. - Postoperative pain: helps control pain after surgical procedures. - Cancer pain: offers long‑term management of malignant disease‑related pain.

Morphine may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea and vomiting: gastrointestinal upset common after dosing. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: sedation or feeling of tiredness. - Pruritus: itching, often localized. - Dry mouth: reduced salivation. - Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be fatal. - Hypotension: significant drop in blood pressure. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Dependence and withdrawal: physical dependence with abrupt cessation. - Neurotoxicity: rare excitatory phenomena such as agitation. - Cardiac arrhythmia: irregular heart rhythm in susceptible patients.

Morphine requires careful monitoring and adherence to safety guidelines. - Dose titration: adjust dose gradually based on patient response and tolerance. - Respiratory monitoring: observe for signs of shallow breathing, especially after initiation. - Concomitant CNS depressants: avoid or limit use with other sedatives. - Renal/hepatic impairment: use lower doses and monitor function. - Pregnancy and lactation: assess risk‑benefit; limited data available. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Morphine can interact with several drug classes, altering its safety or efficacy.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Other opioids: additive respiratory depression. - Central nervous system depressants (e.g., barbiturates): profound sedation. - CYP3A4 inhibitors (e.g., ketoconazole): increased plasma concentrations. - Respiratory depressants (e.g., benzodiazepines): heightened risk of respiratory failure.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance sedative effects. - Anticholinergics: can worsen constipation. - Diuretics: may increase risk of hypotension. - Antihistamines: additive drowsiness. - CYP2D6 inhibitors: modest increase in opioid effect.